AAAAAA

   
Results: 1-14 |
Results: 14

Authors: VOGEL CL
Citation: Cl. Vogel, PHASE-II AND PHASE-III CLINICAL-TRIALS OF TOREMIFENE FOR METASTATIC BREAST-CANCER, Oncology, 12(3), 1998, pp. 9-13

Authors: BURRIS HA VOGEL CL CASTRO D MISHRA L SCHWARZ M SPENCER S OAKES DD KOREY A ORENBERG EK
Citation: Ha. Burris et al., INTRATUMORAL CISPLATIN EPINEPHRINE-INJECTABLE GEL AS A PALLIATIVE TREATMENT FOR ACCESSIBLE SOLID TUMORS - A MULTICENTER PILOT-STUDY/, Otolaryngology and head and neck surgery, 118(4), 1998, pp. 496-503

Authors: BUZDAR AU JONAT W HOWELL A JONES SE BLOMQVIST CP VOGEL CL EIERMANN W WOLTER JM STEINBERG M WEBSTER A LEE D
Citation: Au. Buzdar et al., ANASTROZOLE VERSUS MEGESTROL-ACETATE IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CARCINOMA - RESULTS OF A SURVIVAL UPDATEBASED ON A COMBINED ANALYSIS OF DATA FROM 2 MATURE PHASE-III TRIALS, Cancer, 83(6), 1998, pp. 1142-1152

Authors: BLACKSTEIN M VOGEL CL AMBINDER R COWAN J PEARCE P IGLESIAS J
Citation: M. Blackstein et al., PHASE-II STUDY OF GEMCITABINE IN PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 33, 1997, pp. 664-664

Authors: BUZDAR AU JONES SE VOGEL CL WOLTER J PLOURDE P WEBSTER A
Citation: Au. Buzdar et al., A PHASE-III TRIAL COMPARING ANASTROZOLE (1 AND 10 MILLIGRAMS), A POTENT AND SELECTIVE AROMATASE INHIBITOR, WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CARCINOMA, Cancer, 79(4), 1997, pp. 730-739

Authors: BUZDAR A JONAT W HOWELL A JONES SE BLOMQVIST C VOGEL CL EIERMANN W WOLTER JM AZAB M WEBSTER A PLOURDE PV
Citation: A. Buzdar et al., ANASTROZOLE, A POTENT AND SELECTIVE AROMATASE INHIBITOR, VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - RESULTS OF OVERVIEW ANALYSIS OF 2 PHASE-III TRIALS, Journal of clinical oncology, 14(7), 1996, pp. 2000-2011

Authors: VOGEL CL
Citation: Cl. Vogel, HORMONAL APPROACHES TO BREAST-CANCER-TREATMENT AND PREVENTION - AN OVERVIEW, Seminars in oncology, 23(4), 1996, pp. 2-9

Authors: VOGEL CL SCHOENFELDER J SHEMANO I HAYES DF GAMS RA
Citation: Cl. Vogel et al., WORSENING BONE-SCAN IN THE EVALUATION OF ANTITUMOR RESPONSE DURING HORMONAL-THERAPY OF BREAST-CANCER, Journal of clinical oncology, 13(5), 1995, pp. 1123-1128

Authors: HAYES DF VANZYL JA HACKING A GOEDHALS L BEZWODA WR MAILLIARD JA JONES SE VOGEL CL BERRIS RF SHEMANO I SCHOENFELDER J
Citation: Df. Hayes et al., RANDOMIZED COMPARISON OF TAMOXIFEN AND 2 SEPARATE DOSES OF TOREMIFENEIN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(10), 1995, pp. 2556-2566

Authors: ABELOFF MD",COLE,"VOGEL CL",HOHNEKER,"VOKES EE HORTOBAGYI GN",BURRIS,JONES,"FUMOLEAU P CHANG AY HAVLIN K
Citation: Ee. Abeloff Md",cole,"vogel Cl",hohneker,"vokes et al., ROUND-TABLE QUESTION AND ANSWER SESSION - DISCUSSION, Seminars in oncology, 22(2), 1995, pp. 41-44

Authors: VOGEL CL
Citation: Cl. Vogel, COMBINATION CHEMOTHERAPY WITH VINORELBINE (NAVELBINE) AND MITOXANTRONE FOR METASTATIC BREAST-CANCER - A REVIEW, Seminars in oncology, 22(2), 1995, pp. 61-65

Authors: ATIENZA DM VOGEL CL TROCK B SWAIN SM
Citation: Dm. Atienza et al., PHASE-II STUDY OF ORAL ETOPOSIDE FOR PATIENTS WITH ADVANCED BREAST-CANCER, Cancer, 76(12), 1995, pp. 2485-2490

Authors: VOGEL CL GOMEZ EG
Citation: Cl. Vogel et Eg. Gomez, A PHASE-I CLINICAL-TRIAL OF A COMBINATION OF MITOXANTRONE, 5-FLUOROURACIL, AND HIGH-DOSE LEUCOVORIN GIVEN ON A DAY 1 AND DAY 8 SCHEDULE TO PATIENTS WITH METASTATIC BREAST-CANCER, American journal of clinical oncology, 17(1), 1994, pp. 45-49

Authors: VOGEL CL
Citation: Cl. Vogel, MANAGEMENT OF LOCALLY RECURRENT BREAST-CANCER, Cancer, 72(7), 1993, pp. 2289-2289
Risultati: 1-14 |